BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | -26.0% | 2,936 | -11.1% | 0.05% | -7.0% |
| Q2 2023 | $150 | +11.9% | 3,301 | 0.0% | 0.06% | +3.6% |
| Q1 2023 | $134 | -23.0% | 3,301 | -3.0% | 0.06% | -28.6% |
| Q4 2022 | $174 | -99.9% | 3,404 | 0.0% | 0.08% | -11.5% |
| Q3 2022 | $183,000 | -16.4% | 3,404 | 0.0% | 0.09% | -12.1% |
| Q2 2022 | $219,000 | -30.5% | 3,404 | -16.3% | 0.10% | -1.0% |
| Q1 2022 | $315,000 | -22.8% | 4,067 | -14.4% | 0.10% | -6.5% |
| Q4 2021 | $408,000 | +16.9% | 4,751 | +9.5% | 0.11% | +4.9% |
| Q3 2021 | $349,000 | -12.8% | 4,337 | -12.7% | 0.10% | 0.0% |
| Q2 2021 | $400,000 | -4.5% | 4,970 | 0.0% | 0.10% | -12.1% |
| Q1 2021 | $419,000 | -81.8% | 4,970 | -82.6% | 0.12% | +0.9% |
| Q4 2020 | $2,296,000 | -9.9% | 28,613 | -9.7% | 0.12% | -19.0% |
| Q3 2020 | $2,549,000 | -6.6% | 31,697 | 0.0% | 0.14% | -14.5% |
| Q2 2020 | $2,729,000 | +6.4% | 31,697 | +0.3% | 0.17% | -12.2% |
| Q1 2020 | $2,566,000 | +7.5% | 31,599 | +10.7% | 0.19% | +33.1% |
| Q4 2019 | $2,387,000 | -4.4% | 28,551 | 0.0% | 0.14% | -12.9% |
| Q3 2019 | $2,497,000 | +6.8% | 28,551 | 0.0% | 0.16% | +5.2% |
| Q2 2019 | $2,338,000 | -2.1% | 28,551 | -2.8% | 0.16% | -6.6% |
| Q1 2019 | $2,388,000 | +13.4% | 29,375 | -8.2% | 0.17% | +9.2% |
| Q4 2018 | $2,105,000 | -16.8% | 31,982 | -2.6% | 0.15% | -1.3% |
| Q3 2018 | $2,530,000 | +4.4% | 32,820 | 0.0% | 0.15% | -2.5% |
| Q2 2018 | $2,423,000 | +2.1% | 32,820 | -10.0% | 0.16% | +9.7% |
| Q1 2018 | $2,373,000 | +9.9% | 36,479 | +9.2% | 0.14% | +22.0% |
| Q4 2017 | $2,160,000 | +3.0% | 33,412 | 0.0% | 0.12% | +49.4% |
| Q3 2017 | $2,097,000 | +3.7% | 33,412 | 0.0% | 0.08% | -1.2% |
| Q2 2017 | $2,023,000 | +16.7% | 33,412 | 0.0% | 0.08% | +12.7% |
| Q1 2017 | $1,733,000 | +11.8% | 33,412 | -4.4% | 0.07% | +9.2% |
| Q4 2016 | $1,550,000 | -6.9% | 34,966 | 0.0% | 0.06% | -11.0% |
| Q3 2016 | $1,664,000 | +5.2% | 34,966 | 0.0% | 0.07% | +5.8% |
| Q2 2016 | $1,581,000 | +10.1% | 34,966 | 0.0% | 0.07% | +6.2% |
| Q1 2016 | $1,436,000 | -5.9% | 34,966 | -12.6% | 0.06% | -7.1% |
| Q4 2015 | $1,526,000 | +58.8% | 40,010 | +36.7% | 0.07% | +48.9% |
| Q3 2015 | $961,000 | -63.6% | 29,269 | -22.4% | 0.05% | -62.1% |
| Q2 2015 | $2,637,000 | +5.9% | 37,703 | +3.7% | 0.12% | +5.1% |
| Q1 2015 | $2,491,000 | +2.2% | 36,359 | +9.3% | 0.12% | 0.0% |
| Q4 2014 | $2,438,000 | +32.6% | 33,259 | +29.8% | 0.12% | +25.5% |
| Q3 2014 | $1,839,000 | -11.2% | 25,617 | -10.6% | 0.09% | -12.1% |
| Q2 2014 | $2,072,000 | -8.9% | 28,664 | -7.2% | 0.11% | -10.8% |
| Q1 2014 | $2,274,000 | +5.8% | 30,899 | 0.0% | 0.12% | +3.4% |
| Q4 2013 | $2,149,000 | +3.5% | 30,899 | -2.2% | 0.12% | -5.7% |
| Q3 2013 | $2,076,000 | +68.4% | 31,599 | +77.5% | 0.12% | +73.2% |
| Q2 2013 | $1,233,000 | – | 17,799 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |